Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients
Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19.
Boateng, Savage and Gibbs spoke about the way their status as medical professionals protects them from anti-Black racism, the hope they feel from the world's reaction to the death of George Floyd, and writing as a way to express themselves during this time of COVID‑19 and heightened awareness about racism.
Stanford Health Care can begin pooled testing for COVID‑19
A Stanford test for the coronavirus has been validated for pooled testing. This method greatly increases testing capacity and conserves testing resources, which continue to be in short supply.
